Neuromodulation is an important option for patients with drug-resistant epilepsy—who are not candidates for laser ablation or resective epilepsy surgery—and for seizures that arise in multiple areas of the brain without a clear origin or in areas of the brain that support language, memory, movement or other crucial functions. We are pioneering the application of technologies in the field, employing stimulation parameters and targets directed at relatively novel structures in the brain—such as the thalamus and thalamic subnuclei—broadening the types of epilepsy we can treat with neurostimulation, including generalized onset seizures.  We offer several types of personalized neuromodulation for the treatment of refractory epilepsy, including vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS). The common principle between these different strategies is that, over time, neurostimulation can make the brain less susceptible to seizures.

Clinical studies suggest that these approaches can significantly lower the frequency and severity of seizures when medications alone have been insufficient.